Wegovy on the NHS in Scotland: what you need to know

The myth: a high BMI is all that stands between you and NHS Wegovy in Scotland

It's one of the most common things people tell us when they first get in touch. They've heard that Wegovy is available on the NHS, they've checked their BMI, it qualifies, so surely they can ask their GP and get started? It's an easy conclusion to reach, and it's worth letting go of gently, because the reality is more layered than that.

NICE's appraisal of semaglutide, TA875, recommends Wegovy for adults with a BMI of 35 or above and at least one weight-related comorbidity, but only within a specialist weight management service with multidisciplinary support, and for a maximum of two years. Lower BMI thresholds typically apply for South Asian, Chinese, Middle Eastern, Black African and African-Caribbean backgrounds. Scotland's own clinical guidance, developed through SIGN and delivered via NHS board-commissioned services, sits alongside that NICE recommendation rather than replacing it. In practice, a GP in Scotland can refer someone to a tier 3 service, but whether that service prescribes Wegovy (and how quickly) depends on local health board commissioning, current capacity, and whether the person meets the full clinical criteria for the pathway.

Waiting lists for specialist weight management services in Scotland are real and often long. That isn't a criticism of the NHS; it reflects demand that has grown faster than services can currently absorb. The NHS Inform Scotland page on weight-loss medicines gives an accurate picture of what the pathway looks like in practice.

What Scotland's NHS pathway for Wegovy actually involves

If you're referred to a specialist weight management service in Scotland and eventually prescribed Wegovy, you'll be part of a structured programme. That means dietitian input, physical activity support, and regular clinical review, not just a prescription posted out. The two-year maximum use period under TA875 is real: treatment is intended to be time-limited within the NHS setting, with the expectation that lifestyle changes are embedded before medicines are withdrawn.

The BMI threshold most commonly quoted is 35 with a qualifying comorbidity such as type 2 diabetes, high blood pressure, dyslipidaemia, cardiovascular disease, or obstructive sleep apnoea. A BMI of 30 to 34.9 can qualify in some circumstances if certain specialist-referral criteria are met, but this is a clinical judgement, not an automatic entitlement. Scotland's criteria generally track NICE TA875 but health boards retain discretion in how they commission services, so what's available in one board area may differ from another.

It is also worth knowing that Wegovy holds additional UK authorisations beyond weight management (including a conditional approval from July 2026 for a form of fatty liver disease) but those indications are separate from the weight management pathway and are mentioned here only for completeness. For most people asking about Wegovy on the NHS in Scotland, the weight management route under TA875 is the relevant one. If you'd like to understand more about how semaglutide is accessed through NHS Scotland, including how health board commissioning shapes what's available in your area, that page sets out the detail. If you'd like to compare how the Scottish pathway differs from NHS England's phased rollout, that page covers England's access route in detail.

Can you get Wegovy privately in Scotland if you can't access it on the NHS?

Yes, and for many people in Scotland, a private prescription is currently the faster, more predictable route. Because Wegovy needs a prescription regardless of whether it's NHS-funded or privately prescribed, you still need a clinical assessment, a prescriber's approval, and a GPhC-registered pharmacy to dispense it. None of those requirements go away on the private route; they just happen more quickly.

The private licensed eligibility broadly follows the same clinical principles: adults with a BMI of 30 or above, or a BMI of 27 or above alongside a weight-related condition, may be suitable. A prescriber assesses the whole picture (including other medicines, medical history, and contraindications) before any prescription is issued. BMI alone doesn't guarantee approval on either route.

For context on what private treatment actually costs, this page on Wegovy pricing in the UK explains how private costs are structured and what's typically included. If you've already decided you want to explore the private route, this guide on where to buy Wegovy in Scotland covers what to look for in a regulated provider, including how to verify any online pharmacy on the GPhC register before handing over personal or financial details.

At nume, every consultation is reviewed the same day by a real GPhC-registered prescriber, not an automated system. You can learn more about our clinical team or read about how nume works if you'd like to understand the service before starting. If you're ready to see whether Wegovy is clinically suitable for you, start your free consultation here.